Results 201 to 210 of about 191,742 (248)
Some of the next articles are maybe not open access.

Expression of platelet-derived growth factor B-chain and platelet-derived growth factor β-receptor in fibroblasts of scleroderma

Journal of Dermatological Science, 1998
Scleroderma is a fibrotic disease occurring in a localized or systemic form. The pathogenesis of scleroderma remains poorly understood. Recent studies revealed that various cytokines and growth factors were involved in the development of scleroderma fibrosis.
Zhang Jian-zhong   +3 more
openaire   +3 more sources

Platelet derived growth factor and its receptor in intracerebral hemorrhage

Journal of Zhejiang University (Medical Sciences), 2022
Intracerebral hemorrhage (ICH) is a common and highly disabling or fatal neurological disorder in adults. Recent studies have suggested that the platelet derived growth factor (PDGF) signaling pathway plays an important role in the development of ICH. PDGF is involved in vascular remodeling and can be used as a biomarker of cerebral amyloid angiopathy ...
Baojie, Mao, Ming, Wang, Shu, Wan
openaire   +2 more sources

The platelet-derived growth factor receptor as a therapeutic target

Current Oncology Reports, 2007
Several small molecule tyrosine kinase inhibitors that block the epidermal growth factor receptor and vascular endothelial growth factor receptor function are among the many recently developed targeted anticancer therapeutic agents. Increasing evidence indicates that inhibition of other tumor stromal targets could provide additional and possibly ...
openaire   +3 more sources

[8] methods for studying the platelet-derived growth factor receptor

1985
Publisher Summary This chapter discusses the factors that affect [ 125 I] platelet-derived growth factory (PDGF) binding, or the evaluation of binding, on the evidence that the observed binding is to a functional receptor and on the development of a radioreceptor assay for PDGF. It is a basic 30,000-dalton protein.
Daniel F. Bowen-Pope, Russell Ross
openaire   +3 more sources

Dopamine D(4) and D(2L) Receptor Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Dependent on trans-Activation of the Platelet-Derived Growth Factor Receptor.

Molecular Pharmacology, 2001
The ability of dopamine D(4) and D(2) receptors to activate extracellular signal-regulated kinases (ERKs) 1 and 2 was compared using Chinese hamster ovary (CHO-K1) cells transfected with D(4.2), D(4.4), D(4.7), and D(2L) receptors.
J. Oak, N. Lavine, H. V. Tol
semanticscholar   +1 more source

Structural and functional aspects of the receptors for platelet-derived growth factor

Progress in Growth Factor Research, 1989
Platelet-derived growth factor (PDGF) is a 30 kDa dimer of disulfide-bonded A and B chains. Three isoforms of PDGF have been isolated (PDGF-AA, PDGF-AB and PDGF-BB). These bind with different affinities and specificities to two structurally related cell surface receptors, viz. the alpha-receptor and the beta-receptor.
Lena Claesson-Welsh   +2 more
openaire   +3 more sources

Signal transduction via platelet-derived growth factor receptors

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1998
Platelet-derived growth factor (PDGF) exerts its stimulatory effects on cell growth and motility by binding to two related protein tyrosine kinase receptors. Ligand binding induces receptor dimerization and autophosphorylation, allowing binding and activation of cytoplasmic SH2-domain containing signal transduction molecules.
Arne Östman   +2 more
openaire   +3 more sources

Caveolin Is an Inhibitor of Platelet-Derived Growth Factor Receptor Signaling

Experimental Cell Research, 1999
Caveolin is a major structural component of caveolae and has been implicated in the regulation of the function of several caveolae-associated signaling molecules. Platelet-derived growth factor (PDGF) receptors and caveolin were colocalized in the same subcellular fraction after sucrose density gradient fractionation of fibroblasts.
Yoshihiro Ishikawa   +3 more
openaire   +3 more sources

Role of platelet-derived growth factor in mesangium development and vasculopathies: lessons from platelet-derived growth factor and platelet-derived growth factor receptor mutations in mice

Current Opinion in Nephrology and Hypertension, 2004
The phenotypic consequences of null mutations in the platelet-derived growth factor-B and the platelet-derived growth factor beta-receptor genes in mice have demonstrated that these proteins play pivotal roles in the development of the vascular smooth muscle cell lineage, including pericytes and mesangial cells.The lethality of these mutants has ...
Maria Enge   +5 more
openaire   +3 more sources

Receptors for platelet-derived growth factor on microvascular endothelial cells

1992
Endothelial cells are widely thought to be unresponsive to platelet-derived growth factor (PDGF) and devoid of PDGF receptors. However, in examining the growth factor responses of microvascular endothelial cells isolated from human omental adipose tissue, we detected PDGF-induced tyrosine phosphorylation of an 180-kD glycoprotein, subsequently ...
Frackelton Ar   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy